KIF1B polymorphisms associated with the risk of inflammatory demyelinating disease in Korean population

[1]  Ji-Eun Lee,et al.  Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4 , 2012, Multiple sclerosis.

[2]  H. Kim,et al.  Clinical spectrum of CNS aquaporin-4 autoimmunity , 2012, Neurology.

[3]  B. Müller-Myhsok,et al.  Risk conferring genes in multiple sclerosis , 2011, FEBS letters.

[4]  S. A. Babenko,et al.  Polymorphic locus rs10492972 of the KIF1B gene association with multiple sclerosis in Russia: case control study. , 2011, Molecular genetics and metabolism.

[5]  G. Koutsis,et al.  The rs10492972 KIF1B polymorphism and disease progression in Greek patients with multiple sclerosis , 2011, Journal of Neurology.

[6]  L. Peltonen,et al.  Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis , 2010, Nature Genetics.

[7]  K. Wandinger,et al.  Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen , 2010, Journal of the Neurological Sciences.

[8]  G. Comi,et al.  Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort , 2010, European journal of neurology.

[9]  W. Talbot,et al.  Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons , 2009, Nature Genetics.

[10]  C. Duijn,et al.  Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis , 2008, Nature Genetics.

[11]  C. Duijn,et al.  EVI5 is a risk gene for multiple sclerosis , 2008, Genes and Immunity.

[12]  L. Peltonen,et al.  Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations , 2008, Journal of Medical Genetics.

[13]  I. Boldogh,et al.  Mitochondria on the move. , 2007, Trends in cell biology.

[14]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[15]  S. Gabriel,et al.  Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.

[16]  B. Weinshenker,et al.  Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.

[17]  K. Fujihara,et al.  OSMS is NMO, but not MS: proven clinically and pathologically , 2006, The Lancet Neurology.

[18]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[19]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[20]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[21]  P C O'Brien,et al.  The clinical course of neuromyelitis optica (Devic’s syndrome) , 1999, Neurology.

[22]  N. Hirokawa,et al.  KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria , 1994, Cell.

[23]  J. Todd,et al.  CD226 Gly307Ser association with multiple autoimmune diseases , 2009, Genes and Immunity.

[24]  J. Haines,et al.  The expanding genetic overlap between multiple sclerosis and type I diabetes , 2009, Genes and Immunity.

[25]  J. V. van Noort.  Antigen-specific therapies in multiple sclerosis. , 1998, Biotherapy.